Inhibrx Biosciences
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 22,213 $23.41 $520,051
Sale
KAYYEM JON FAIZ director
 Common Stock 1,959 $27.61 $54,088
Sale
KAYYEM JON FAIZ director
 Common Stock 7,541 $26.87 $202,589
Sale
LAPPE MARK director, officer: Chief Execut..
 Common Stock 754 $26.29 $19,820
Sale
LAPPE MARK director, officer: Chief Execut..
 Common Stock 25,246 $25.53 $644,631
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 1,392 $28.46 $39,618
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 17,681 $27.57 $487,501
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 20,927 $26.84 $561,576
Sale
KAYYEM JON FAIZ director
 Common Stock 6,767 $30.12 $203,822
Sale
KAYYEM JON FAIZ director
 Common Stock 2,733 $29.33 $80,153
Sale
LAPPE MARK director, officer: Chief Execut..
 Common Stock 1,150 $32.38 $37,242
Sale
LAPPE MARK director, officer: Chief Execut..
 Common Stock 912 $30.67 $27,969
Sale
LAPPE MARK director, officer: Chief Execut..
 Common Stock 6,773 $30.15 $204,199
Sale
LAPPE MARK director, officer: Chief Execut..
 Common Stock 1,767 $28.86 $50,990
Sale
LAPPE MARK director, officer: Chief Execut..
 Common Stock 4,333 $27.45 $118,937
Sale
LAPPE MARK director, officer: Chief Execut..
 Common Stock 4,106 $26.57 $109,096
Sale
LAPPE MARK director, officer: Chief Execut..
 Common Stock 6,959 $25.36 $176,480
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 12,349 $33.9 $418,643
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 27,651 $33.34 $921,746
Sale
KAYYEM JON FAIZ director
 Common Stock 5,928 $30.58 $181,255
Sale
KAYYEM JON FAIZ director
 Common Stock 3,572 $29.39 $104,978
Sale
LAPPE MARK director, officer: Chief Execut..
 Common Stock 121 $31.51 $3,812
Sale
LAPPE MARK director, officer: Chief Execut..
 Common Stock 2,892 $30.81 $89,091
Sale
LAPPE MARK director, officer: Chief Execut..
 Common Stock 14,006 $29.93 $419,130
Sale
LAPPE MARK director, officer: Chief Execut..
 Common Stock 8,981 $28.66 $257,422
Purchase
VIKING GLOBAL INVESTORS LP 10 percent owner
 Common Stock 333,333 $30 $9,999,990
Purchase
VIKING GLOBAL INVESTORS LP 10 percent owner
 Common Stock 1,000,000 $30 $30,000,000
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 100 $30.52 $3,052
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 10,893 $29.68 $323,304
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 5,954 $28.97 $172,493
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 4,262 $27.76 $118,300
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 11,136 $26.78 $298,178
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 6,207 $26.06 $161,761
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 1,448 $24.67 $35,721
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 2,493 $15.66 $39,033
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 37,507 $14.86 $557,241
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 15,500 $18.47 $286,208
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 24,500 $17.7 $433,626
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 40,000 $17.17 $686,800
Sale
ECKELMAN BRENDAN P. officer: Chief Scientific Officer
 Common Stock 400 $25.04 $10,016
Sale
ECKELMAN BRENDAN P. director, officer: Chief Scient..
 Common Stock 17,000 $19.02 $323,340
Sale
WAGNER KLAUS W. officer: Chief Medical Officer
 Common Stock 19,559 $25.29 $494,647
Sale
ECKELMAN BRENDAN P. director, officer: Chief Scient..
 Common Stock 17,000 $25.9 $440,300
Sale
WAGNER KLAUS W. officer: Chief Medical Officer
 Common Stock 156,474 $24.32 $3,805,448
Purchase
VIKING GLOBAL INVESTORS LP 10 percent owner
 Common Stock 180,219 $18.91 $3,408,482
Purchase
VIKING GLOBAL INVESTORS LP 10 percent owner
 Common Stock 85,304 $19.31 $1,647,306
Purchase
VIKING GLOBAL INVESTORS LP 10 percent owner
 Common Stock 46,161 $19.43 $897,001

Showing 50 to 97 of 97 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: